Hint: It's Good to be a Merck Manager | GenomeWeb

The Wall Street Journal Health Blog reports that many top people at Merck will keep their positions as the merger with Schering-Plough goes through. Merck's CEO, Dick Clark, will stay in charge. Also keeping their spots are Kenneth Frazier, the head of global human health, Peter Kim, the head of research labs, and Willie Deese, the head of manufacturing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.